Alpha Tau Medical Ltd. (DRTSW)
Price:
1.19 USD
( + 0.02 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
BioNTech SE
VALUE SCORE:
6
2nd position
ADMA Biologics, Inc.
VALUE SCORE:
11
The best
Harmony Biosciences Holdings, Inc.
VALUE SCORE:
12
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
No data to display
DESCRIPTION
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.
NEWS

Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 2.2% – Should You Sell?
defenseworld.net
2026-02-19 03:31:07Alpha Tau Medical Ltd. (NASDAQ: DRTSW - Get Free Report)'s share price traded down 2.2% during trading on Wednesday. The stock traded as low as $1.10 and last traded at $1.1250. 15,291 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 71,665 shares. The stock had previously closed
No data to display

Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 2.2% – Should You Sell?
defenseworld.net
2026-02-19 03:31:07Alpha Tau Medical Ltd. (NASDAQ: DRTSW - Get Free Report)'s share price traded down 2.2% during trading on Wednesday. The stock traded as low as $1.10 and last traded at $1.1250. 15,291 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 71,665 shares. The stock had previously closed










